COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Single-Use Visualization Devices with Vizient Inc., the largest healthcare performance improvement company in the U.S. The agreement is effective Feb. 1, 2022.
The contract with Vizient — whose members represent more than half of the hospitals and health systems in the U.S and serve 97 percent of all the academic medical centers — will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by offering Vizient members pre-negotiated pricing and terms for Ambu’s full suite of single-use products in Bronchoscopy, Urology, ENT and GI. This agreement also includes access to all new single use endoscopy launches.
The creation by GPOs of specific single-use endoscope categories comes as the transition to single-use endoscopy continues to accelerate, with an eye on expanding hospitals’ capacity and avoiding costly and unnecessary expenses associated with workflow management and patient cross-contamination.
“Our vision at Ambu is to be the most innovative single-use endoscopy company and this agreement with Vizient enables us to better serve its member health systems, hospitals, and healthcare providers across the U.S.,” said Juan Jose Gonzalez, CEO of Ambu A/S. “We consider Vizient an exceptional company and are excited to work closely with its member organizations. Our portfolio breadth, innovation ecosystem and attractive economics mean we can be the partner of choice for health systems in their efforts to prevent device-related infections, boost healthcare economics and improve clinical workflows.”
Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScope™ in 2009. A decade later, in fiscal 2020/2021, more than 1.5 million Ambu single-use endoscopes were used around the world, and Ambu has now developed scopes for a broad range of clinical areas making Ambu the largest and most innovative supplier of single-use endoscopes.
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions. We continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on patient care and the work of healthcare professionals. Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,500 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com or ambuUSA.com. Follow us on Facebook, Twitter, LinkedIn, or YouTube and subscribe to our podcast “Endoscopy Insights.”